Edgar S. Diaz-Cruz, Ph.D.
Affiliations: | 2005 | Ohio State University, Columbus, Columbus, OH |
Area:
Molecular Biology, OncologyGoogle:
"Edgar Diaz-Cruz"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Robert W. Brueggemeier | grad student | 2005 | Ohio State | |
| (Interrelationships between aromatase and cyclooxygenase -2 and their role in the autocrine and paracrine mechanisms in breast cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| McDonnell AM, Pyles HM, Diaz-Cruz ES, et al. (2019) Enoxacin and Epigallocatechin Gallate (EGCG) Act Synergistically to Inhibit the Growth of Cervical Cancer Cells in Culture. Molecules (Basel, Switzerland). 24 |
| Miermont AM, Cabrera MC, Frech SM, et al. (2012) Association of Over-Expressed Estrogen Receptor Alpha with Development of Tamoxifen Resistant Hyperplasia and Adenocarcinomas in Genetically Engineered Mice. Anatomy & Physiology : Current Research |
| Cabrera MC, Díaz-Cruz ES, Kallakury BV, et al. (2012) The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the cyclin-CDK-Rb pathway. Cancer Prevention Research (Philadelphia, Pa.). 5: 810-21 |
| Furth PA, Nakles RE, Millman S, et al. (2011) Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer. Breast Cancer Research : Bcr. 13: 220 |
| Díaz-Cruz ES, Sugimoto Y, Gallicano GI, et al. (2011) Comparison of increased aromatase versus ERα in the generation of mammary hyperplasia and cancer Cancer Research. 71: 5477-5487 |
| Furth PA, Cabrera MC, Díaz-Cruz ES, et al. (2011) Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models. Annals of the New York Academy of Sciences. 1229: 147-55 |
| Nakles RE, Shiffert MT, Díaz-Cruz ES, et al. (2011) Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content. Molecular Endocrinology (Baltimore, Md.). 25: 549-63 |
| Diaz-Cruz ES, Cabrera MC, Nakles R, et al. (2010) BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer. Breast Disease. 32: 85-97 |
| Su B, Díaz-Cruz ES, Landini S, et al. (2008) Suppression of aromatase in human breast cells by a cyclooxygenase-2 inhibitor and its analog involves multiple mechanisms independent of cyclooxygenase-2 inhibition. Steroids. 73: 104-11 |
| Davis DD, Díaz-Cruz ES, Landini S, et al. (2008) Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 108: 23-31 |